Targeting structural and stereochemical complexity by organocascade catalysis: construction of spirocyclic oxindoles having multiple stereocenters

Angewandte Chemie - International Edition

Volumn 48, Issue 39, 2009, Pages 7200-7203

  Bencivenni, Giorgio ^a   Wu, Li Yuan ^b   Mazzanti, Andrea ^a   Giannichi, Berardino ^a   Pesciaioli, Fabio ^a   Song, Mao Ping ^b   Bartoli, Giuseppe ^a   Melchiorre, Paolo ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b ZHENGZHOU UNIVERSITY   (China)

Author keywords

Cascade catalysis; Heterocycles; Molecular complexity; Organocatalysis; Spiro compounds

Indexed keywords

CASCADE CATALYSIS; HETEROCYCLES; MOLECULAR COMPLEXITY; ORGANOCATALYSIS; SPIRO COMPOUNDS;

CARBONYLATION; RATE CONSTANTS; REACTION KINETICS;

CATALYSIS;

INDOLE DERIVATIVE; KETONE; OXINDOLE; SPIRO COMPOUND;

ARTICLE; CATALYSIS; CHEMICAL STRUCTURE; CHEMISTRY; STEREOISOMERISM;

CATALYSIS; INDOLES; KETONES; MOLECULAR STRUCTURE; SPIRO COMPOUNDS; STEREOISOMERISM;

EID: 70349784950     PISSN: 14337851     EISSN: None     Source Type: Journal    
DOI: 10.1002/anie.200903192     Document Type: Article

References (60)

1. a) Stereochemical aspects of drug action and disposition, (Eds. : M. Eichelbaum, B. Testa, A. Somogyi), Springer, Heidelberg, 2003;
2. b) A. M. Thayer, Chem. Eng. News 2007, 85, 11-19. Many drugs used today are natural products or natural-product derivatives, see :
3. c) D. J. Newman, G. M. Cragg, J. Nat. Prod. 2007, 70, 461-477.
4. J. T. Mohr, M. R. Krout, B. M. Stoltz, Nature 2008, 455, 323-332.
5. K. C. Nicolaou, S. A. Snyder, Proc. Natl. Acad. Sci. USA 2004, 101, 11929-11936.
6. a) Quaternary Stereocenters. Challenges and Solutions in Organic Synthesis (Eds.: J. Christoffers, A. Baro), Wiley-VCH, Weinheim, 2006;
7. b) C. J. Douglas, L. E. Overman, Proc. Natl. Acad. Sci. USA 2004, 101, 5363-5367;
8. c) B. M. Trost, J. Chunhui, Synthesis 2006, 369-396.
9. For recent organocatalytic, asymmetric construction of oxindoles bearing an all-carbon quaternary stereocenter, see : a) P. Galzerano, G. Bencivenni, F. Pesciaioli, A. Mazzanti, B. Giannichi, L. Sambri, G. Bartoli, P. Melchiorre, Chem. Eur. J. 2009, DOI: 10.1002/chem.200802466;
10. b) T. Bui, S. Syed, C. F. Barbas III,J. Am. Chem. Soc. 2009, 131, 8758-8759; for an early example, see:
11. c) I. D. Hills, G. Fu, Angew. Chem. 2003, 115, 4051-4054;
12. Angew. Chem. Int. Ed. 2003, 42, 3921-3924.
13. a) H. Lin, S. J. Danishefsky, Angew. Chem. 2003, 115, 38-53;
14. Angew. Chem. Int. Ed. 2003, 42, 36-51;
15. b) C. V. Galliford, K. A. Scheidt, Angew. Chem. 2007, 119, 8902-8912;
16. Angew. Chem. Int. Ed. 2007, 46, 8748-8758.
17. a) H. Venkatesan, M. C. Davis, Y. Altas, Snyder, D. C. Liotta, J. Org. Chem. 2001, 66, 3653-3661;
18. b) M. M.-C. Lo, C. S. Neumann, S. Nagayama, E. O. Perlstein, S. L. Schreiber, J. Am. Chem. Soc. 2004, 126, 16077-16086;
19. c) S. Kotha, A. C. Deb, K. Lahiri, E. Manivannan, Synthesis 2009, 165-193, and references therein.
20. a) E. J. Corey, Angew. Chem. 2002, 114, 1724-1741;
21. Angew. Chem. Int. Ed. 2002, 41, 1650-1667. For application to the synthesis of (+) and (-) Spirotryprostatin B, see:
22. b) P. R. Sebahar, R. M. Williams, J. Am. Chem. Soc. 2000, 122, 5666-5667 For the use of the asymmetric palladium-catalyzed trimethylenemethane [3+2]-cycloaddition in the synthesis of marcfortine B, see :
23. c) B. M. Trost, N. Cramer, S. M. Silverman, J. Am. Chem. Soc. 2007, 129, 12396-12397;
24. d) B. M. Trost, N. Cramer, H. Bernsmann, J. Am. Chem. Soc. 2007, 129, 3086-3087.
25. a) A. B. Dounay, L. E. Overman, Chem. Rev. 2003, 103, 2945-2963.For the use of the intramolecular Heck reaction in the stereocontrolled total synthesis of (±)-gelsemine, see:
26. b) A. Madin, C.J. O'Donnell, T. Oh, D. W. Old, L. E. Overman, M. J. Sharp, J. Am. Chem. Soc. 2005, 127, 18054-18065.
27. a) D. Enders, C. Grondal, M. R. M. Hüttl, Angew. Chem. 2007, 119, 1590-1601;
28. Angew. Chem. Int. Ed. 2007, 46, 1570-1581;
29. b) A. M. Walji, D. W. C. MacMillan, Synlett 2007, 1477-1489;
30. c) K. C. Nicolaou, D. J. Edmonds, P. G. Bulger, Angew. Chem. 2006, 118, 7292-7344;
31. Angew. Chem. Int. Ed. 2006, 45, 71347186.
32. a) B. List, Chem. Commun. 2006, 819-824. For meaningful examples, see:
33. b) T. Bui, C. F. Barbas III, Tetrahedron Lett. 2000, 41, 6951-6954;
34. c) Y. Huang, A. M. Walji, C. H. Larsen, D. W. C. MacMillan, J. Am. Chem. Soc. 2005, 127, 15051-15053;
35. d) M. Marigo, T. Schulte, J. Franzen, K. A. Jørgensen, J. Am. Chem. Soc. 2005, 127, 15710-15711;
36. e) D. Enders, M. R. M. Hüttl, C. Grondal, G. Raabe, Nature 2006, 441, 861-863. See also reference [14].
37. K. Kumar, H. Waldmann, Angew. Chem. 2009, 121, 3272-3290;
38. Angew. Chem. Int. Ed. 2009, 48, 3224-3242.
39. For recent reviews on aminocatalysis: a) P. Melchiorre, M. Marigo, A. Carlone, G. Bartoli, Angew. Chem. 2008, 120, 6232-6265
40. Angew. Chem. Int. Ed. 2008, 47, 6138-6171;
41. b)C. F. Barbas III, Angew. Chem. 2008, 120, 44-50;
42. Angew. Chem. Int. Ed. 2008, 47, 42-47.
43. For early examples on secondary amine mediated Diels-Alder reactions of enones which exploit the transient formation of the dienamine intermediate I, see: a) R. Thayumanavan, B. Dhevalapally, K. Sakthivel, F. Tanaka, C. F. Barbas III, Tetrahedron Lett. 2002, 43, 3817-3820; for application in the synthesis of spirocyclic compounds, see:
44. b) D. B. Ramachary, N. S. Chowdari, C. F. Barbas III, Angew. Chem. 2003, 115, 4365-4369;
45. Angew. Chem. Int. Ed. 2003, 42, 4233-4237. See also:
46. c) N. Halland, P. S. Aburel, K. A. Jørgensen, Angew. Chem. 2004, 116, 1292-1297;
47. Angew. Chem. Int. Ed. 2004, 43, 1272-1277.
48. For recent reviews, see: a) G. Bartoli, P. Melchiorre, Synlett 2008, 1759-1771;
49. b) Y.-C. Chen, Synlett 2008, 1919-1930, and references therein.
50. F. Pesciaioli, F. De Vincentiis, P. Galzerano, G. Bencivenni, G. Bartoli, A. Mazzanti, P. Melchiorre, Angew. Chem. 2008, 120, 8831-8834;
51. Angew. Chem. Int. Ed. 2008, 47, 8703-8706.
52. 1H NMR spectroscopy. However, the stereochemical outcome of the process, as discussed in the Supporting Information, prompted us to propose a stepwise double-Michael addition sequence, leading to a formal Diels-Alder product such as 3, more than a concerted cycloaddition mechanism.
53. E. A. Peterson, L. E. Overman, Proc. Natl. Acad. Sci. USA 2004, 101, 11943-11948.
54. "Spiroindolinone derivatives": J.-J. Liu, Z. Zhang (Hoffmann-La Roche AG), PCT Int. Appl. WO 2008/055812, 2008. The other enantiomer, ent-7, is also accessible with high level of stereoselectivity (see Figure 2 in the Supporting Information).
55. a) P. Chène, Nat. Rev. Cancer 2003, 3, 102-109;
56. b) K. Ding, Y. Lu, Z. Nikolovska-Coleska, S. Qiu, Y. Ding, W. Gao, J. Stuckey, K. Krajewski, P. P. Roller, Y. Tomita, D. A. Parrish, J. R. Deschamps, S. Wang, J. Am. Chem. Soc. 2005, 127, 10130-10131.
57. A. Penon, A. Carlone, A. Mazzanti, M. Locatelli, L. Sambri, G. Bartoli, P. Melchiorre, Chem. Eur. J. 2008, 14, 4788-4791.
58. The relative and absolute configurations of compounds 3 and 6 were assigned by NMR NOE analyses, X-ray crystallography (for compounds 3c and 6n), and by means of TD-DFT calculations of the electronic circular dichroism (ECD) spectra, as described in the Supporting Information. CCDC 726678 (6n) and 726679 (3 c) contain the supplementary crystallographic data for this paper. These data can be obtained free of charge from The Cambridge Crystallographic Data Centre via www.ccdc. cam.ac.uk/data-request/cif.
59. T. E. Nielsen, S. L. Schreiber, Angew. Chem. 2008, 120, 52-61;
60. Angew. Chem. Int. Ed. 2008, 47, 48-56.